Compare tickers
Up to 5 tickers, ~30 metrics, weighted verdict. Best in green, worst in red.
Verdict
Weighted score 0-100 across 1 tickers · best in green
25
25
15
20
15
Total: 100 · normalized in scoring
#1
ALNY
score 50.0
Ranks first despite weak momentum with YTD down 28.5% because strong value score shows PEG ratio only 0.52.
value 50growth 50quality 50momentum 50sentiment 50
ALNY
Alnylam Pharmaceuticals, Inc.
$286.12
-3.22%
ALNY
Alnylam Pharmaceuticals, Inc.
$286.12
-3.22%
Snapshot
Price
286.12
Day %
-3.22
1M %
-3.37
3M %
-10.21
YTD %
-28.5
Market cap
38200619008.0
ADV ($)
314770906.9482422
Beta
0.302
Tao zone
Current zone
Pullback
Dist 21-EMA %
-3.89
Dist ATR (σ)
-1.16
Tao grade
—
Confluence
1
Valuation
P/E (ttm)
71.88944
P/E (fwd)
20.5874
P/S
8.910965
EV/EBITDA
47.292
P/B
35.503162
FCF yield
0.0054
PEG
0.52
Growth
Revenue yoy
0.964
EPS yoy
—
FCF yoy
—
Quality
Gross margin
0.80827004
Operating margin
0.23016001
Net margin
0.12550001
ROE
0.90356004
ROA
0.10062
Debt / Equity
2.76
Interest cov.
2.28
Technicals
RSI(14)
39.7
MACD signal
neutral
vs 50-DMA
-7.13
vs 200-DMA
-25.52
vs 52w high
-42.26
HV-30
30.7
Sentiment
Analyst rec
1.76667
Target upside
55.81
Insider buy-sell 90d
—
Risk
Short interest
5.390000000000001
Days to cover
4.81
Next earnings
2026-07-30
Full ALNY dashboard →